• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation method. III. Morphology of the microspheres during dissolution studies.

作者信息

Bodmeier R, McGinity J W

机构信息

College of Pharmacy, University of Texas, Austin 78712-1074.

出版信息

J Microencapsul. 1988 Oct-Dec;5(4):325-30. doi: 10.3109/02652048809036729.

DOI:10.3109/02652048809036729
PMID:3236152
Abstract

Poly(dl-lactide) (PLA) microspheres containing quinidine or quinidine sulphate were prepared by the emulsification-solvent evaporation technique. The in vitro release profile of quinidine or quinidine sulphate from the microspheres was characterized by three phases: a lag time, a rapid release phase (burst), and a slow release phase. Drug release was studied as a function of the ionic strength of the dissolution medium, to demonstrate the importance of the water imbition into the microspheres which induced the drug release. The lag time increased with increasing ionic strength. The microspheres stayed intact during the dissolution study as shown by scanning electron microscopy (SEM). Disintegration of microspheres which was initially observed was an artifact introduced during the SEM procedure. The high vacuum applied either during the coating of the microspheres with gold-palladium or during the actual observation in the scanning electron microscope caused the microspheres to collapse or rupture.

摘要

相似文献

1
Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation method. III. Morphology of the microspheres during dissolution studies.
J Microencapsul. 1988 Oct-Dec;5(4):325-30. doi: 10.3109/02652048809036729.
2
Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. II. Some process parameters influencing the preparation and properties of microspheres.
J Microencapsul. 1987 Oct-Dec;4(4):289-97. doi: 10.3109/02652048709021821.
3
Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. I. Methods and morphology.通过溶剂蒸发技术制备的含奎尼丁碱和硫酸奎尼丁的聚乳酸微球。I. 方法与形态。
J Microencapsul. 1987 Oct-Dec;4(4):279-88. doi: 10.3109/02652048709021820.
4
The preparation and evaluation of drug-containing poly(dl-lactide) microspheres formed by the solvent evaporation method.通过溶剂蒸发法制备含药聚(dl-丙交酯)微球及其评价
Pharm Res. 1987 Dec;4(6):465-71. doi: 10.1023/a:1016419303727.
5
In vitro and in vivo release of poly(DL-lactic acid) microspheres containing neurotensin analogue prepared by novel oil-in-water solvent evaporation method.
J Pharm Sci. 1992 Aug;81(8):808-11. doi: 10.1002/jps.2600810817.
6
In vitro degradation and dissolution behaviours of microspheres prepared by three low molecular weight polyesters.三种低分子量聚酯制备的微球的体外降解和溶解行为
J Microencapsul. 2000 Sep-Oct;17(5):577-86. doi: 10.1080/026520400417630.
7
Nimesulide PLA microspheres as a potential sustained release system for the treatment of inflammatory diseases.尼美舒利聚乳酸微球作为一种治疗炎症性疾病的潜在缓释系统。
Int J Pharm. 2005 May 13;295(1-2):201-11. doi: 10.1016/j.ijpharm.2005.03.003.
8
Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route.
J Microencapsul. 1993 Oct-Dec;10(4):449-60. doi: 10.3109/02652049309015322.
9
Microencapsulation using poly(DL-lactic acid). I: Effect of preparative variables on the microcapsule characteristics and release kinetics.聚(DL-乳酸)微囊化。I:制备变量对微囊特性及释放动力学的影响。
J Microencapsul. 1990 Apr-Jun;7(2):229-44. doi: 10.3109/02652049009021836.
10
Preparation and characterization of polylactic acid microspheres containing bovine insulin by a w/o/w emulsion solvent evaporation method.采用复乳溶剂挥发法制备含牛胰岛素的聚乳酸微球及其表征
Chem Pharm Bull (Tokyo). 1997 Sep;45(9):1539-43. doi: 10.1248/cpb.45.1539.

引用本文的文献

1
Impact of dispersion time interval and particle size on release profiles of propranolol HCl and carbamazepines from microparticle blends system.分散时间间隔和粒径对盐酸普萘洛尔和卡马西平从小粒子混合物系统中释放的影响。
Sci Rep. 2022 Jun 20;12(1):10360. doi: 10.1038/s41598-022-14678-w.
2
PLGA/PLA-Based Long-Acting Injectable Depot Microspheres in Clinical Use: Production and Characterization Overview for Protein/Peptide Delivery.PLGA/PLA 基长效注射储库微球的临床应用:蛋白/肽给药的生产和特性概述。
Int J Mol Sci. 2021 Aug 18;22(16):8884. doi: 10.3390/ijms22168884.
3
Development of sustained-release microspheres for the delivery of SAR 1118, an LFA-1 antagonist intended for the treatment of vascular complications of the eye.
用于递送 SAR 1118 的缓释微球的开发,SAR 1118 是一种 LFA-1 拮抗剂,旨在治疗眼部血管并发症。
J Ocul Pharmacol Ther. 2013 Mar;29(2):236-48. doi: 10.1089/jop.2012.0210. Epub 2012 Dec 20.
4
Real time monitoring of biomaterial-mediated inflammatory responses via macrophage-targeting NIR nanoprobes.通过靶向巨噬细胞的近红外纳米探针实时监测生物材料介导的炎症反应。
Biomaterials. 2011 Dec;32(35):9383-90. doi: 10.1016/j.biomaterials.2011.08.064. Epub 2011 Sep 3.